Christopher Graham

Dr. Christopher Martin Graham is a Canadian infectious diseases specialist based in Mississauga, Ontario.

Career and Affiliations

University of Toronto

Graham is a lecturer at the University of Toronto.

Trillium Health Partners

Graham is an investigator at the Institute for Better Health at Trillium Health Partners.1) He is also the physician lead for THP's Antimicrobial Stewardship Program.

Ontario COVID-19 Science Advisory Table

Graham formerly served as a member of the Drugs & Biologics Clinical Practice Guidelines Working Group of the Ontario COVID-19 Science Advisory Table.2)



Graham is a site investigator for the CATCO Study, the Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial.3) 4) The SOLIDARITY Trial is funded by UNITAID, Elon Musk, the Chan Zuckerberg Initiative, Twitter’s Jack Dorsey, PayPal’s Peter Thiel, and the Bill & Melinda Gates Foundation.5) 6) 7)

He is also a site investigator for CONCOR-1, and assisted with the ILIAD study by Eiger Biopharmaceuticals for a COVID-19 treatment.

Doctor Graham, Christopher - Infectious Disease Specialist. (2022, January 28). Mississauga Halton Local Health Integration Network.
About Us. (2021, June 30). Wayback Machine; Ontario COVID-19 Science Advisory Table.
Ali, K., Azher, T., Baqi, M., Binnie, A., Borgia, S., Carrier, F. M., Cavayas, Y. A., Chagnon, N., Cheng, M. P., Conly, J., Costiniuk, C., Daley, P., Daneman, N., Douglas, J., Downey, C., Duan, E., Duceppe, E., Durand, M., English, S., & Farjou, G. (2022). Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial. CMAJ: Canadian Medical Association Journal = Journal de l’Association Medicale Canadienne, cmaj.211698.
Bill and Melinda Gates fund global ivermectin & fluvoxamine clinical trial targeting COVID-19: Together COVID-19 trial. (2021, February 11). TrialSiteNews.
Emergent Ventures. Mercatus Center. Retrieved March 3, 2022, from
Fast funding for COVID-19 science. Fast Grants. Retrieved March 3, 2022, from